ZEVIN ASSET MANAGEMENT LLC - Novozymes A/S ownership

Novozymes A/S's ticker is NVZMY and the CUSIP is 670108109. A total of 14 filers reported holding Novozymes A/S in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
ZEVIN ASSET MANAGEMENT LLC ownership history of Novozymes A/S
ValueSharesWeighting
Q3 2023$2,949
-12.6%
73,347
+1.2%
0.59%
-12.4%
Q2 2023$3,374
-9.0%
72,489
-0.1%
0.68%
-10.4%
Q1 2023$3,707
+28.4%
72,554
+26.8%
0.76%
+20.6%
Q4 2022$2,887
-99.9%
57,209
-0.3%
0.63%
-7.7%
Q3 2022$2,873,000
-10.0%
57,393
+8.0%
0.68%
-5.7%
Q2 2022$3,191,000
-12.6%
53,160
-0.2%
0.72%
+3.0%
Q1 2022$3,653,000
-13.6%
53,252
+4.7%
0.70%
-8.3%
Q4 2021$4,228,000
+22.9%
50,864
+1.2%
0.76%
+16.3%
Q3 2021$3,439,000
-9.4%
50,278
-0.0%
0.66%
-13.2%
Q2 2021$3,794,000
+24.2%
50,301
+5.7%
0.76%
+11.9%
Q1 2021$3,054,000
+32.7%
47,585
+18.0%
0.68%
+25.0%
Q4 2020$2,301,000
-7.2%
40,326
+2.3%
0.54%
-20.1%
Q3 2020$2,480,000
+14.2%
39,407
+5.0%
0.68%
+2.4%
Q2 2020$2,171,000
+27.9%
37,546
+0.6%
0.66%
+4.6%
Q1 2020$1,697,000
-2.5%
37,311
+4.6%
0.63%
+18.2%
Q4 2019$1,741,000
+16.1%
35,662
-0.0%
0.53%
+10.6%
Q3 2019$1,500,000
-7.6%
35,667
+2.2%
0.48%
-7.6%
Q2 2019$1,624,000
+1.4%
34,899
+0.2%
0.52%0.0%
Q1 2019$1,602,000
+2.8%
34,8150.0%0.52%
-7.4%
Q4 2018$1,558,000
-18.0%
34,815
+0.2%
0.56%
+1.8%
Q3 2018$1,901,000
+16.8%
34,729
+7.6%
0.56%
+14.2%
Q2 2018$1,627,000
+1.6%
32,270
+5.5%
0.49%
+16.8%
Q1 2018$1,601,000
-4.6%
30,585
+4.1%
0.42%
+9.2%
Q4 2017$1,678,000
+30.3%
29,380
+17.4%
0.38%
+25.7%
Q3 2017$1,288,000
+19.5%
25,025
+1.7%
0.30%
+11.4%
Q2 2017$1,078,000
+11.1%
24,600
+0.6%
0.27%
+11.0%
Q1 2017$970,000
+20.5%
24,455
+4.9%
0.24%
+16.7%
Q4 2016$805,000
+176.6%
23,320
+282.6%
0.21%
+172.7%
Q4 2015$291,000
+10.2%
6,0950.0%0.08%0.0%
Q3 2015$264,000
-9.0%
6,095
-0.2%
0.08%0.0%
Q2 2015$290,0006,1100.08%
Other shareholders
Novozymes A/S shareholders Q3 2017
NameSharesValueWeighting ↓
ZEVIN ASSET MANAGEMENT LLC 50,864$4,228,0000.76%
Moloney Securities Asset Management, LLC 5,650$464,0000.08%
Boston Common Asset Management, LLC 10,371$852,0000.03%
ST GERMAIN D J CO INC 5,000$416,0000.02%
Private Capital Group, LLC 324$27,0000.01%
MAR VISTA INVESTMENT PARTNERS LLC 723$59,0000.00%
CAPTRUST FINANCIAL ADVISORS 2,379$198,0000.00%
PNC FINANCIAL SERVICES GROUP, INC. 3,597$295,0000.00%
View complete list of Novozymes A/S shareholders